FI922958A - Farmaceutisk sammansaettning - Google Patents

Farmaceutisk sammansaettning Download PDF

Info

Publication number
FI922958A
FI922958A FI922958A FI922958A FI922958A FI 922958 A FI922958 A FI 922958A FI 922958 A FI922958 A FI 922958A FI 922958 A FI922958 A FI 922958A FI 922958 A FI922958 A FI 922958A
Authority
FI
Finland
Prior art keywords
sammansaettning
pharmaceutical
pharmaceutical sammansaettning
Prior art date
Application number
FI922958A
Other languages
English (en)
Other versions
FI922958A0 (fi
FI109454B (fi
Inventor
Birgit Hauer
Armin Meinzer
Ulrich Posanski
Jacky Vonderscher
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI922958(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI922958A0 publication Critical patent/FI922958A0/fi
Publication of FI922958A publication Critical patent/FI922958A/fi
Priority to FI961513A priority Critical patent/FI116199B/fi
Application granted granted Critical
Publication of FI109454B publication Critical patent/FI109454B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
FI922958A 1991-06-27 1992-06-25 Menetelmä farmaseuttisen koostumuksen valmistamiseksi FI109454B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI961513A FI116199B (fi) 1991-06-27 1996-04-03 Transesteröityjä maissiöljytuotteita ja niiden käyttö farmaseuttisessa koostumuksessa

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds
GB9113872 1991-06-27

Publications (3)

Publication Number Publication Date
FI922958A0 FI922958A0 (fi) 1992-06-25
FI922958A true FI922958A (fi) 1992-12-28
FI109454B FI109454B (fi) 2002-08-15

Family

ID=10697415

Family Applications (2)

Application Number Title Priority Date Filing Date
FI922958A FI109454B (fi) 1991-06-27 1992-06-25 Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI961513A FI116199B (fi) 1991-06-27 1996-04-03 Transesteröityjä maissiöljytuotteita ja niiden käyttö farmaseuttisessa koostumuksessa

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI961513A FI116199B (fi) 1991-06-27 1996-04-03 Transesteröityjä maissiöljytuotteita ja niiden käyttö farmaseuttisessa koostumuksessa

Country Status (38)

Country Link
EP (2) EP0539319B1 (fi)
JP (2) JP2653958B2 (fi)
KR (3) KR0131064B1 (fi)
CN (1) CN1077798C (fi)
AT (1) AT403436B (fi)
AU (1) AU659460B2 (fi)
CA (2) CA2175842C (fi)
CH (2) CH684163A5 (fi)
CY (1) CY1906A (fi)
CZ (1) CZ281790B6 (fi)
DE (3) DE4244986B4 (fi)
DK (2) DK0539319T3 (fi)
EE (1) EE03108B1 (fi)
ES (2) ES2142818T3 (fi)
FI (2) FI109454B (fi)
FR (2) FR2678169B1 (fi)
GB (2) GB9113872D0 (fi)
GR (1) GR3032366T3 (fi)
HK (2) HK57196A (fi)
HU (1) HU216792B (fi)
IE (1) IE73662B1 (fi)
IL (3) IL118546A (fi)
IT (1) IT1254401B (fi)
LU (1) LU88138A1 (fi)
MX (1) MX9203236A (fi)
MY (1) MY109512A (fi)
NO (2) NO303964B1 (fi)
NZ (1) NZ243309A (fi)
PH (1) PH30337A (fi)
PT (2) PT539319E (fi)
RO (2) RO111021B1 (fi)
RU (1) RU2143919C1 (fi)
SA (1) SA92130213B1 (fi)
SK (1) SK278759B6 (fi)
TW (1) TW267943B (fi)
UA (1) UA35559C2 (fi)
UY (1) UY23864A1 (fi)
ZA (1) ZA924719B (fi)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
ES2168271T3 (es) * 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
DE69435104D1 (de) * 1993-09-28 2008-07-31 Scherer Gmbh R P Herstellung von Weichgelatinekapseln
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
WO1995022343A1 (fr) * 1994-02-17 1995-08-24 Shiseido Company, Ltd. Composition d'emulsion a base de cyclosporine
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ES2133655T3 (es) * 1994-03-31 1999-09-16 Unilever Nv Aceites con bajo contenido de acidos grasos saturados.
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
MY129435A (en) 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
CA2231404C (en) 1994-11-03 2009-02-17 Arzneimittelwerk Dresden Gmbh Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
CA2220451A1 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Methods and compositions for improving digestion and absorption in the small intestine
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
ES2227700T3 (es) * 1996-06-19 2005-04-01 Novartis Ag Preparados de capsulas blandas que contienen ciclosporina.
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6306434B1 (en) * 1997-02-12 2001-10-23 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
JP4718653B2 (ja) * 1997-03-12 2011-07-06 アボツト・ラボラトリーズ シクロスポリンの投与のための親水性二成分系
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
CA2285983A1 (en) 1997-04-29 1998-11-05 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
DE69804624T2 (de) 1997-07-29 2002-09-19 Upjohn Co Selbstemulgierende formulierung enthaltend lipophile verbindungen
SI0999826T1 (en) * 1997-07-29 2004-12-31 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
SI0989851T1 (en) 1997-07-29 2003-04-30 Pharmacia & Upjohn Company Self-emulsifying formulation for acidic lipophilic compounds
US6657104B1 (en) 1997-10-16 2003-12-02 Texas Systems, University Of The Board Of The Regents Transgenic mouse model for cardiac hypertrophy and methods of use thereof
KR100587551B1 (ko) 1997-12-10 2006-06-08 싸이클로스포린 테라퓨틱스 리미티드 오메가-3 지방산 오일을 함유하는 약학 조성물
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
PT982035E (pt) * 1998-08-18 2004-08-31 Panacea Biotec Ltd Composicao de ciclosporina compreendendo um veiculo hidrofilo
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
AU2127400A (en) * 1999-11-02 2001-05-14 Cipla Limited A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
CA2417971C (en) * 2000-08-08 2010-01-19 Kao Corporation Oil/fat composition
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
ES2326040T3 (es) 2001-10-19 2009-09-29 Isotechnika Inc. Sintesis de analogos de ciclosporina.
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
CA2683415C (en) 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
KR20170102223A (ko) 2014-11-07 2017-09-08 시그모이드 파마 리미티드 사이클로스포린을 포함하는 조성물
WO2020050182A1 (ja) * 2018-09-06 2020-03-12 株式会社カマタ カプセル充填用液状組成物及びカプセル剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (fi) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
GB2230440B (en) * 1989-02-09 1993-05-19 Sandoz Ltd Novel cyclosporin galenic forms
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
IL118546A (en) 1998-09-24
IL118546A0 (en) 1996-10-16
AT403436B (de) 1998-02-25
NO325267B1 (no) 2008-03-17
CY1906A (en) 1992-06-24
RU2143919C1 (ru) 2000-01-10
IL102310A (en) 1997-03-18
DE4219526A1 (de) 1993-03-18
DE4244930C2 (de) 1999-11-11
JP3420897B2 (ja) 2003-06-30
HUT62201A (en) 1993-04-28
FR2678169A1 (fr) 1992-12-31
CA2175842A1 (en) 1992-12-28
HK157696A (en) 1996-08-30
GB9213393D0 (en) 1992-08-05
AU1852792A (en) 1993-03-11
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
CH684163A5 (de) 1994-07-29
EP0953630A1 (en) 1999-11-03
FI116199B (fi) 2005-10-14
UY23864A1 (es) 1995-05-29
GB2257359A (en) 1993-01-13
EP0953630B1 (en) 2004-09-08
FR2685706A1 (fr) 1993-07-02
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
IT1254401B (it) 1995-09-14
NZ243309A (en) 1995-02-24
IL102310A0 (en) 1993-01-14
CZ197792A3 (en) 1993-01-13
KR0131064B1 (ko) 1998-04-17
DE4219526C2 (de) 1999-04-22
FI961513A (fi) 1996-04-03
LU88138A1 (fr) 1994-03-01
TW267943B (fi) 1996-01-11
EP0539319B1 (en) 1999-12-08
JPH09118894A (ja) 1997-05-06
NO922506L (no) 1992-12-28
AU659460B2 (en) 1995-05-18
GB9113872D0 (en) 1991-08-14
GB2257359B (en) 1996-01-10
RO111021B1 (ro) 1996-06-28
CZ281790B6 (cs) 1997-01-15
ES2142818T3 (es) 2000-05-01
NO964382L (no) 1992-12-28
FR2685706B1 (fi) 1994-12-23
KR930000113A (ko) 1993-01-15
SK197792A3 (en) 1994-03-09
CA2072509A1 (en) 1992-12-28
FI922958A0 (fi) 1992-06-25
RO111110B1 (ro) 1996-06-28
ITRM920476A1 (it) 1993-12-23
NO922506D0 (no) 1992-06-25
DK0953630T3 (da) 2004-11-01
JP2653958B2 (ja) 1997-09-17
FI109454B (fi) 2002-08-15
EE03108B1 (et) 1998-08-17
CA2072509C (en) 1996-07-30
CA2175842C (en) 2002-05-07
JPH05186365A (ja) 1993-07-27
EP0539319A2 (en) 1993-04-28
HU9201975D0 (en) 1992-09-28
KR100231385B1 (en) 1999-11-15
NO964382D0 (no) 1996-10-15
FR2678169B1 (fr) 1994-08-26
ZA924719B (en) 1993-12-27
HU216792B (hu) 1999-08-30
ES2227921T3 (es) 2005-04-01
KR100231384B1 (en) 1999-11-15
PH30337A (en) 1997-04-02
CN1077798C (zh) 2002-01-16
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
DE4244986B4 (de) 2008-07-24
NO303964B1 (no) 1998-10-05
DK0539319T3 (da) 2000-05-22
PT539319E (pt) 2000-05-31
IE73662B1 (en) 1997-06-18
CH685764A5 (de) 1995-09-29
FI961513A0 (fi) 1996-04-03
GR3032366T3 (en) 2000-04-27
PT953630E (pt) 2004-11-30
HK57196A (en) 1996-04-12
ATA129892A (de) 1997-07-15
CN1079907A (zh) 1993-12-29
SK278759B6 (sk) 1998-02-04
EP0539319A3 (en) 1993-06-09

Similar Documents

Publication Publication Date Title
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
FI922316A (fi) Farmaceutisk sammansaettning
FI923581A (fi) Farmaceutisk kombinationsformation
DK0616523T3 (da) Lægemidler
NO920067D0 (no) Foradditiv for droevtyggere
DK0585252T3 (da) Farmaceutiske formuleringer
NO942923L (no) Medikamenter
NO923859D0 (no) Medikament
FI930882A (fi) Farmaceutiska foereningar
FI910116A (fi) sigma-delta-modulator foer d/a-omvandlare
ATA131391A (de) Reibring
MX9200622A (es) Composicion farmaceutica
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A (fi) Farmaceutiska foereningar
ATA170491A (de) Mauerstein
FI921786A (fi) Farmaceutisk foerening
FI921785A (fi) Farmaceutisk foerening
BR9206845A (pt) Composto famacêutico
SE9103213D0 (sv) Farmaceutisk komposition
SE9101348D0 (sv) Pharmaceutical composition
NO920564L (no) Farmasoeytiske adenosinholdige preparater
TH13625EX (th) เอเซียโลไกลโคโปรตีน-ตัวยาคอนจูเกท
DK75791D0 (da) Novel pharmaceutical preparations

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

MA Patent expired